title: Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock.
authors.forename: Fabio Silvio
authors.initials: FS
authors.lastname: Taccone
authors.forename: Alexandre
authors.initials: A
authors.lastname: Brasseur
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Vincent
authors.forename: Daniel
authors.initials: D
authors.lastname: De Backer
mesh_terms: D005260:Female; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008875:Middle Aged; D011724:Pyridazines / Q000627:therapeutic use*; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology*; D000077464:Simendan; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan